ACIP Vaccine Recommendations

Advisory Committee on Immunization Practices (ACIP) from CDC

The Advisory Committee on Immunization Practices (ACIP) develops recommendations on how to use vaccines and passive immunizations to control diseases in the United States. Learn more about ACIP.

Results (13)
  • Diphtheria
  • Hepatitis B
  • Hib (Haemophilus Influenzae Type B)
  • Pertussis
  • Polio
  • Tetanus
Current
Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
MMWR, February 7, 2020, 69 (5);136-139
  • Diphtheria
  • Pertussis
  • Tetanus
Current
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR, January 24, 2020, Vol 69 (3);77-83
  • Diphtheria
  • Pertussis
  • Tetanus
Current
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, April 27, 2018; 67 (2):1-44
  • Diphtheria
  • Pertussis
  • Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
MMWR, February 22, 2013;62(07):131-5
  • Diphtheria
  • Pertussis
  • Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
MMWR, June 29, 2012; 61(25):468-70
  • Diphtheria
  • Pertussis
  • Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
MMWR, October 21, 2011; 60(41):1424-1426
  • Diphtheria
  • Pertussis
  • Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
MMWR, January 14, 2011; 60(01):13-15
  • Diphtheria
  • Pertussis
  • Tetanus
Archived
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, May 30, 2008; 57 (04):1-47,51
  • Diphtheria
  • Pertussis
  • Tetanus
Archived
Preventing Tetanus, Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
MMWR, December 15, 2006;55(RR-17):1-33
  • Diphtheria
  • Pertussis
  • Tetanus
Archived
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among Adolescents
If you are using the HTML version of this document, be sure to access all the HTML links to get the complete content of the document, which includes important appendices.
MMWR, March 24, 2006, Vol. 55(RR03):1-49
  • Pertussis
Archived
CDC Treatment Guidelines: Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of Pertussis
MMWR, December 9, 2005, Vol. 54(RR14):1-16
  • Diphtheria
  • Pertussis
  • Tetanus
Archived
Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
MMWR November 17, 2000 / Vol. 49 / No. RR-13

This page was updated on .